Mice lacking inducible nitric oxide synthase show strong resistance to anti-Fas antibody-induced fulminant hepatitis

Archives of Biochemistry and Biophysics

Volumn 411, Issue 1, 2003, Pages 63-72

  Chang, BaoJun ^a   Nishikawa, Manabu ^a   Sato, Eisuke ^a   Inoue, Masayasu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Fas; Hepatitis; iNOS; Mitochondria; NO

Indexed keywords

FAS ANTIBODY; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE RESISTANCE; HEPATITIS; HISTOLOGY; LIVER FUNCTION; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; WILD TYPE;

EID: 0037370212     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9861(02)00723-3     Document Type: Article

References (31)

1. Nagata S., Golstein P. Science. 267:1995;1449-1456.
2. Hiramatsu N., Hayashi N., Katayama K., Mochizuki K., Kawanishi Y., Kasahara A., Fusamoto H., Kamada T. Hepatology. 19:1994;1354-1359.
3. Mochizuki K., Hayashi N., Hiramatsu N., Katayama K., Kawanishi Y., Kasahara A., Fusamoto H., Kamada T. J. Hepatol. 24:1996;1-7.
4. Galle P.R., Hofmann W.J., Walczak H., Schaller H., Otto G., Stremmel W., Krammer P.H., Runkel L. J. Exp. Med. 182:1995;1223-1230.
5. Mita E., Hayashi N., Iio S., Takehara T., Hijioka T., Kasahara A., Fusamoto H., Kamada T. Biochem. Biophys. Res. Commun. 204:1994;468-474.
6. Kondo T., Suda T., Fukuyama H., Adachi M., Nagata S. Nat. Med. 4:1997;409-413.
7. Kim Y.M., de Vera M.E., Watkins S.C., Billiar T.R. J. Biol. Chem. 272:1997;1402-1411.
8. Kim Y.M., Talanian R.V., Billiar T.R. J. Biol. Chem. 272:1997;31138-31148.
9. Park S.K., Lin H.L., Murphy S. Biochem. J. 322:1997;609-613.
10. Gardner C.R., Heck D.E., Yang C.S., Thomas P.E., Zhang X.J., DeGeorge G.L., Laskin J.D., Laskin D.L. Hepatology. 27:1998;748-754.
11. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Nature. 364:1993;806-809.
12. Schierwagen C., Bylund-Fellenius A.C., Lundberg C. J. Pharmacol. Methods. 23:1990;179-186.
13. Beuge J.A., Aust S.D. Methods Enzymol. 52:1978;302-310.
14. Grishko V.I., Druzhyna N., LeDoux S.P., Wilson G.L. Nucleic Acids Res. 27:1999;4510-4516.
15. Nishikawa M., Nishiguchi S., Shiomi S., Tamori S., Koh N., Takeda T., Kubo S., Hirohashi K., Kinoshita H., Sato E., Inoue M. Cancer Res. 61:2001;1843-1845.
16. Kim, Peter K.M., Kwon Y.G., Chung H.T., Kim Y.M. Ann. N.Y. Acad. Sci. 962:2002;42-52.
17. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., Kim Y.M. Biochem. Biophys. Res. Commun. 282:2001;1075-1079.
18. Streetz K., Leifeld L., Grundmann D., Ramakers J., Eckert K., Spengler U., Brenner D., Manns M., Trautwein C. Gastroenterology. 119:2000;446-460.
19. Binder C., Schulz M., Hiddemann W., Oellerich M. Anticancer Res. 19:1999;1715-1720.
20. Ajuebor M.N., Virag L., Flower R.J., Perretti M., Szabo C. Immunology. 95:1998;625-630.
21. Corriveau C.C., Madara P.J., Van Dervort A.L., Tropea M.M., Wesley R.A., Danner R.L. J. Infect. Dis. 177:1998;116-126.
22. Beauvais F., Michel L., Dubertret L. J. Cell Physiol. 165:1995;610-614.
23. Forslund T., Nilsson H.M., Sundqvist T. Biochem. Biophys. Res. Commun. 274:2000;482-487.
24. Belenky S.N., Robbins R.A., Rennard S.I., Gossman G.L., Nelson K.J., Rubinstein I. J. Lab. Clin. Med. 122:1993;388-394.
25. Nishikawa M., Sato E.F., Utsumi K., Inoue M. Cancer Res. 56:1996;4535-4540.
26. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Cell. 86:1996;147-157.
27. Orrenius S., McConkey D.J., Bellomo G., Nicotera P. Trends Pharmacol. 10:1989;281-285.
28. Nishikawa M., Sato E., Kuroki T., Utsumi K., Inoue M. Hepatology. 28:1998;1474-1480.
29. Fromenty B., Pessayre D. Pharmacol. Ther. 67:1995;101-154.
30. Galle P.R., Krammer P.H. Semin. Liver Dis. 18:1998;141-151.
31. Feldmann G., Lamboley C., Moreau A., Bringuier A. Biomed. Pharmacother. 52:1998;378-385.